Back to search
Familial Chylomicronemia Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Chylomicronemia Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Chylomicronemia Syndrome trials you may qualify forThis is a treatment program for the use of plozasiran in adults (AROAPOC3-EAP-002) and adolescents (AROAPOC3-EAP-003) with familial chylomicronemia syndrome (FC…
This is a randomized, double-blinded, placebo controlled, two periods phase 3 clinical study. The primary objective of the study was to evaluate the efficacy an…
The purpose of AROAPOC3-3001 is to evaluate the efficacy and safety of ARO-APOC3 (plozasiran) in adult participants with familial chylomicronemia syndrome (FCS)…